Lista de obras - Alan H. Bryce - Dominio Público Uruguay

A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona

artículo científico publicado en 2015

A Prospective Genome-Wide Study of Prostate Cancer Metastases Reveals Association of Wnt Pathway Activation and Increased Cell Cycle Proliferation with Primary Resistance to Abiraterone Acetate-Prednisone.

artículo científico publicado en 2017

A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer.

artículo científico publicado en 2016

A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: A department of defense prostate cancer clinical trials consortium study

artículo científico publicado en 2017

A novel report of cig-FISH and cytogenetics in POEMS syndrome.

artículo científico publicado en 2008

Alternative Outpatient Chemotherapy Scheduling Method to Improve Patient Service Quality and Nurse Satisfaction

artículo científico publicado en 2017

Androgen receptor splice variant 7 in castration-resistant prostate cancer: Clinical considerations.

artículo científico publicado en 2016

Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations

scientific article published on 20 March 2020

Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers

artículo científico publicado en 2016

Clonal analyses of refractory testicular germ cell tumors

scientific article published on 14 March 2019

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

artículo científico

Comprehensive Characterization of Cancer Driver Genes and Mutations

article

Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib

scientific article published on 01 December 2016

Current Imaging Techniques for and Imaging Spectrum of Prostate Cancer Recurrence and Metastasis: A Pictorial Review

artículo científico publicado en 2020

Current status and future directions of personalized medicine.

artículo científico publicado en 2013

Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer.

artículo científico publicado en 2016

Development and clinical utility of abiraterone acetate as an androgen synthesis inhibitor.

artículo científico publicado en 2011

Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations

scientific article published on 21 February 2019

Evaluation of pre-analytical factors affecting plasma DNA analysis.

artículo científico publicado en 2018

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery.

artículo científico publicado en 2017

Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer.

artículo científico

Genomic profiling proves metastasis of cutaneous melanoma to vitreal fluid

scientific article published on 17 February 2020

Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial

artículo científico publicado en 2021

Impact of timing of administration of bone supportive therapy on pain palliation from radium-223

scientific article published on 10 November 2018

Implementing individualized medicine into the medical practice

artículo científico publicado en 2014

Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma

artículo científico publicado en 2014

Mutational Profile in Vulvar, Vaginal, and Urethral Melanomas: Review of 37 Cases With Focus on Primary Tumor Site

artículo científico publicado en 2019

NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.

artículo científico publicado en 2017

Natural history and therapy of 66 patients with mixed cryoglobulinemia

artículo científico publicado en 2006

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

artículo científico publicado en 2015

Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: analysis from the phase 2 TRITON2 study

artículo científico publicado en 2020

PANDA: pathway and annotation explorer for visualizing and interpreting gene-centric data.

artículo científico publicado en 2015

PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation

artículo científico publicado en 2015

Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome

artículo científico publicado en 2008

Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumors

artículo científico publicado en 2011

Phase II trial of oral topotecan and intravenous carboplatin with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: A North Central Cancer Treatment Group Study.

artículo científico publicado en 2010

Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non-V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team.

artículo científico

Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience

artículo científico publicado en 2018

Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL.

artículo científico publicado en 2017

Response to rituximab in patients with type II cryoglobulinemia

artículo científico publicado en 2006

Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencing

artículo científico publicado en 2019

Simultaneous characterization of somatic events and HPV-18 integration in a metastatic cervical carcinoma patient using DNA and RNA sequencing.

artículo científico publicado en 2014

Systemic treatment for metastatic castrate resistant prostate cancer: Does seqence matter?

scientific article published on 13 January 2020

Targeting TMPRSS2 in SARS-CoV-2 Infection

scientific article published on 19 July 2020

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

article

The Effect of Enzalutamide and Bicalutamide on Patient-reported Quality of Life Outcomes: Results from the TERRAIN Study

artículo científico publicado en 2016

Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.

artículo científico publicado en 2009

Vemurafenib-associated gingival hyperplasia in patient with metastatic melanoma

artículo científico publicado en 2014

Lista de obras de Alan H. Bryce

A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona

A Prospective Genome-Wide Study of Prostate Cancer Metastases Reveals Association of Wnt Pathway Activation and Increased Cell Cycle Proliferation with Primary Resistance to Abiraterone Acetate-Prednisone.

A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer.

A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: A department of defense prostate cancer clinical trials consortium study

A novel report of cig-FISH and cytogenetics in POEMS syndrome.

Alternative Outpatient Chemotherapy Scheduling Method to Improve Patient Service Quality and Nurse Satisfaction

Androgen receptor splice variant 7 in castration-resistant prostate cancer: Clinical considerations.

Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations

Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers

Clonal analyses of refractory testicular germ cell tumors

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

Comprehensive Characterization of Cancer Driver Genes and Mutations

Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib

Current Imaging Techniques for and Imaging Spectrum of Prostate Cancer Recurrence and Metastasis: A Pictorial Review

Current status and future directions of personalized medicine.

Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer.

Development and clinical utility of abiraterone acetate as an androgen synthesis inhibitor.

Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations

Evaluation of pre-analytical factors affecting plasma DNA analysis.

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery.

Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer.

Genomic profiling proves metastasis of cutaneous melanoma to vitreal fluid

Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial

Impact of timing of administration of bone supportive therapy on pain palliation from radium-223

Implementing individualized medicine into the medical practice

Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma

Mutational Profile in Vulvar, Vaginal, and Urethral Melanomas: Review of 37 Cases With Focus on Primary Tumor Site

NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.

Natural history and therapy of 66 patients with mixed cryoglobulinemia

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: analysis from the phase 2 TRITON2 study

PANDA: pathway and annotation explorer for visualizing and interpreting gene-centric data.

PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation

Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome

Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumors

Phase II trial of oral topotecan and intravenous carboplatin with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: A North Central Cancer Treatment Group Study.

Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non-V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team.

Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience

Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL.

Response to rituximab in patients with type II cryoglobulinemia

Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencing

Simultaneous characterization of somatic events and HPV-18 integration in a metastatic cervical carcinoma patient using DNA and RNA sequencing.

Systemic treatment for metastatic castrate resistant prostate cancer: Does seqence matter?

Targeting TMPRSS2 in SARS-CoV-2 Infection

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

The Effect of Enzalutamide and Bicalutamide on Patient-reported Quality of Life Outcomes: Results from the TERRAIN Study

Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.

Vemurafenib-associated gingival hyperplasia in patient with metastatic melanoma